Login / Signup

Tamoxifen ameliorates obstructive nephropathy through Src and the PI3K/Akt/mTOR pathway.

Chang Seong KimIn Jin KimJoon Seok ChoiEun Hui BaeSeong Kwon MaYong-Soo Kim
Published in: Biology of the cell (2018)
Our findings suggest that tamoxifen is a novel therapeutic option for the prevention and treatment of renal fibrosis.
Keyphrases
  • breast cancer cells
  • estrogen receptor
  • positive breast cancer
  • tyrosine kinase
  • mouse model
  • replacement therapy
  • liver fibrosis